Figures & data
![](/cms/asset/f0b3fe57-1a13-4b03-8e7d-874ad25dff13/tbbb_a_1012149_uf0001_b.gif)
Fig. 3. 15d-PGJ2-induced intracellular redox alteration.
Notes: 15d-PGJ2 directly modifies thioredoxin and thioredoxin reductase and induces the intracellular redox alteration and ROS-dependent cell death.
![Fig. 3. 15d-PGJ2-induced intracellular redox alteration.Notes: 15d-PGJ2 directly modifies thioredoxin and thioredoxin reductase and induces the intracellular redox alteration and ROS-dependent cell death.](/cms/asset/86ed8f58-c460-4de9-82c6-748898329283/tbbb_a_1012149_f0003_b.gif)
Fig. 4. Schematic mechanism of p53-dependent apoptosis induced by 15d-PGJ2.
Notes: 15d-PGJ2 activates p53 pathway through covalent modification of ATM, a protein kinase that phosphorylates p53, and thereby induces p53-dependent apoptotic cell death. 15d-PGJ2 also inhibits the degradation of p53 protein via covalent modification of proteasome.
![Fig. 4. Schematic mechanism of p53-dependent apoptosis induced by 15d-PGJ2.Notes: 15d-PGJ2 activates p53 pathway through covalent modification of ATM, a protein kinase that phosphorylates p53, and thereby induces p53-dependent apoptotic cell death. 15d-PGJ2 also inhibits the degradation of p53 protein via covalent modification of proteasome.](/cms/asset/2b584857-8e6d-4e52-8cb9-cae900d9f46f/tbbb_a_1012149_f0004_b.gif)